Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johann D D Pitout

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Msphere|December 22, 2021
Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time PeriodsJohann D D Pitout
Current Opinion in Investigational Drugs (London, England : 2000)|August 4, 2009
IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microfloraJohann D D Pitout
Expert Review of Anti-Infective Therapy|October 14, 2008
Multiresistant Enterobacteriaceae: new threat of an old problemJohann D D Pitout
Expert Review of Anti-Infective Therapy|December 4, 2012
Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatmentJohann D D Pitout
Drugs|February 20, 2010
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choicesJohann D D Pitout
Frontiers in Microbiology|February 2, 2012
Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic ResistanceJohann D D Pitout
The Lancet. Infectious Diseases|August 14, 2010
The latest threat in the war on antimicrobial resistanceJohann D D Pitout
Microbiology Spectrum|September 8, 2018
Transmission Surveillance for Antimicrobial-Resistant Organisms in the Health SystemJohann D D Pitout
Current Pharmaceutical Design|September 1, 2012
Enterobacteriaceae that produce extended-spectrum β-lactamases and AmpC β-lactamases in the community: the tip of the iceberg?Johann D D Pitout
Antimicrobial Agents and Chemotherapy|February 26, 2014
Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineageGisele Peirano, Johann D D Pitout
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Msphere|December 22, 2021
Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time PeriodsJohann D D Pitout
Current Opinion in Investigational Drugs (London, England : 2000)|August 4, 2009
IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microfloraJohann D D Pitout
Expert Review of Anti-Infective Therapy|October 14, 2008
Multiresistant Enterobacteriaceae: new threat of an old problemJohann D D Pitout
Expert Review of Anti-Infective Therapy|December 4, 2012
Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatmentJohann D D Pitout
Drugs|February 20, 2010
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choicesJohann D D Pitout
Frontiers in Microbiology|February 2, 2012
Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic ResistanceJohann D D Pitout
The Lancet. Infectious Diseases|August 14, 2010
The latest threat in the war on antimicrobial resistanceJohann D D Pitout
Microbiology Spectrum|September 8, 2018
Transmission Surveillance for Antimicrobial-Resistant Organisms in the Health SystemJohann D D Pitout
Current Pharmaceutical Design|September 1, 2012
Enterobacteriaceae that produce extended-spectrum β-lactamases and AmpC β-lactamases in the community: the tip of the iceberg?Johann D D Pitout
Antimicrobial Agents and Chemotherapy|February 26, 2014
Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineageGisele Peirano, Johann D D Pitout
Pageof 14